Hexagon Bio Revenue and Competitors
Estimated Revenue & Valuation
- Hexagon Bio's estimated annual revenue is currently $16.4M per year.
- Hexagon Bio's estimated revenue per employee is $155,000
- Hexagon Bio's total funding is $206M.
Employee Data
- Hexagon Bio has 106 Employees.
- Hexagon Bio grew their employee count by 6% last year.
Hexagon Bio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder and CEO | Reveal Email/Phone |
2 | Founder and VP, Synthetic Biology | Reveal Email/Phone |
3 | Head Engineering | Reveal Email/Phone |
4 | Head Operations | Reveal Email/Phone |
5 | SVP | Reveal Email/Phone |
6 | Director Automation | Reveal Email/Phone |
7 | Director - Fungal Genetics/Sequence the Earth | Reveal Email/Phone |
8 | Co-Founder and Chief Technology Officer | Reveal Email/Phone |
9 | Director, Lab Operations | Reveal Email/Phone |
10 | Laboratory Manager | Reveal Email/Phone |
Hexagon Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Hexagon Bio?
Hexagon Bio is a data-driven biotech developing targeted small molecule therapeutics. Our proprietary platform combines data science and synthetic biology to discover and engineer drugs from DNA sequences. We are mining fungal genomes for inspiration for the next generation of targeted therapies for diseases with unmet needs.
keywords:Biotechnology
$206M
Total Funding
106
Number of Employees
$16.4M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Hexagon Bio News
Named for the transversely isotropic shape's natural design and engineering properties, Hexagon Bio's proprietary discovery platform enables...
We all want to be the fungi. Hexagon Bio wants to be the fungi by using those organisms to create new treatments for cancer and infectious diseases, and investors are joining the party with $61 million. That financing adds to the $47 million series A raised nearly a year ago to the day for a ge ...
Hexagon Bio, a biopharmaceutical company pioneering the discovery of medicines encoded in the global metagenome, today announced that it has raised $61 million to fuel the continued development of its platform to design and develop new therapeutics mined from microbial genomes. Nextech Invest le ...
Hexagon Bio has raised a $47 million Series A led by The Column Group, with participation from 8VC and Two Sigma Ventures. The Menlo Park-based biotech startup is developing a molecule discovery platform to help combat cancer and infectious diseases. The company was valued at $33.2 million in 20 ...
Other Companies in Menlo Park
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.5M | 106 | 5% | N/A |
#2 | $15M | 108 | 21% | N/A |
#3 | $22.2M | 109 | 9% | $45.1M |
#4 | $26.3M | 110 | 7% | N/A |
#5 | $15.4M | 110 | 13% | N/A |